Drawing for VAPORE FORM OF MEDICATION, BEING ABLE TO BE SMOKED/INHAILED ORALLY. MEDICATION AND VITAMINS IN E-LIQUID FORM TO BE SMOKED USED WITH AN E-VAPOR, OR E-CIGGARETTE. VITAMINS IN LIQUID/VAPOR FORM IN CARTLIGES THAT ATTACH TO AND E-CIGARETTE THAT IS RECHARGABLE.

USPTO serial 86348091

VAPORE FORM OF MEDICATION, BEING ABLE TO BE SMOKED/INHAILED ORALLY. MEDICATION AND VITAMINS IN E-LIQUID FORM TO BE SMOKED USED WITH AN E-VAPOR, OR E-CIGGARETTE. VITAMINS IN LIQUID/VAPOR FORM IN CARTLIGES THAT ATTACH TO AND E-CIGARETTE THAT IS RECHARGABLE.

Reviewed by CopyMark Law Group

Status 622
Filing date
—
Status date
Registration date
—
Examiner
—
Law office
UNKNOWN

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VAPORE FORM OF MEDICATION, BEING ABLE TO BE SMOKED/INHAILED ORALLY. MEDICATION AND VITAMINS IN E-LIQUID FORM TO BE SMOKED USED WITH AN E-VAPOR, OR E-CIGGARETTE. VITAMINS IN LIQUID/VAPOR FORM IN CARTLIGES THAT ATTACH TO AND E-CIGARETTE THAT IS RECHARGABLE.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus, namely, electric vaporizer for upper respiratory conditions; Medical apparatus, namely, electric vaporizer that emits menthol for treatment of upper respiratory conditions; Vaporizers for medical purposesACTIVE—
011Electric vaporizersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance